# Mission BioCapital's Biotech Investments: 29 Startups in Its Portfolio (2026) > The 29 Biotech startups Mission BioCapital has backed, by stage: $2.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/mission-biocapital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 8 - [Shape Therapeutics](https://millionrounds.com/company/shape-therapeutics) - [Tune Therapeutics](https://millionrounds.com/company/tune-therapeutics) - [Nuvig Therapeutics](https://millionrounds.com/company/nuvig-therapeutics) - [Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics) - [Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics) - [EpiBiologics](https://millionrounds.com/company/epibiologics) - [QurAlis](https://millionrounds.com/company/quralis) - [Arkuda Therapeutics](https://millionrounds.com/company/arkuda-therapeutics) ## Stage not reported 7 - [Dren Bio](https://millionrounds.com/company/dren-bio) - [Pionyr Immunotherapeutics](https://millionrounds.com/company/pionyr-immunotherapeutics) - [Jupiter BioVentures](https://millionrounds.com/company/jupiter-bioventures) - [*M* Mitokinin](https://millionrounds.com/company/mitokinin) - [AmbAgon Therapeutics](https://millionrounds.com/company/ambagon-therapeutics) - [*AT* Avexegen Therapeutics](https://millionrounds.com/company/avexegen-therapeutics) - [Tangible Science](https://millionrounds.com/company/tangible-science) ## Series C and later 6 - [Circle Pharma](https://millionrounds.com/company/circle-pharma) - [Glycomine](https://millionrounds.com/company/glycomine) - [*ST* SiteOne Therapeutics](https://millionrounds.com/company/siteone-therapeutics) - [Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics) - [Vivace Therapeutics](https://millionrounds.com/company/vivace-therapeutics) - [Symic Bio](https://millionrounds.com/company/symic-bio) ## Pre-seed and seed 5 - [Cloverleaf Bio](https://millionrounds.com/company/cloverleaf-bio) - [Enodia Therapeutics](https://millionrounds.com/company/enodia-therapeutics) - [TippingPoint Biosciences](https://millionrounds.com/company/tippingpoint-biosciences) - [Deck Bio](https://millionrounds.com/company/deck-bio) - [*BB* Beech Biotech](https://millionrounds.com/company/beech-biotech) ## Series A 3 - [*PT* Progentos Therapeutics](https://millionrounds.com/company/progentos-therapeutics) - [March Biosciences](https://millionrounds.com/company/march-biosciences) - [*CT* Comet Therapeutics](https://millionrounds.com/company/comet-therapeutics) ## Segment by segment ### Series B 8 startups · $1.1B raised - [**Shape Therapeutics**](https://millionrounds.com/company/shape-therapeutics) A biotechnology company developing RNA technologies to shape the future of gene therapy United States $260M - [**Tune Therapeutics**](https://millionrounds.com/company/tune-therapeutics) Tune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020. United States $175M - [**Nuvig Therapeutics**](https://millionrounds.com/company/nuvig-therapeutics) Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune. United States $161M - [**Mediar Therapeutics**](https://millionrounds.com/company/mediar-therapeutics) Mediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019. United States $161M - [**Nocion Therapeutics**](https://millionrounds.com/company/nocion-therapeutics) Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. United States $112M - [**EpiBiologics**](https://millionrounds.com/company/epibiologics) EpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022. United States $107M - [**QurAlis**](https://millionrounds.com/company/quralis) QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD. United States $94M - [**Arkuda Therapeutics**](https://millionrounds.com/company/arkuda-therapeutics) Arkuda Therapeutics is a biotechnology company based in Watertown, MA, dedicated to developing medicines for neurodegenerative diseases. United States $64M ### Stage not reported 7 startups · $734M raised - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M - [**Pionyr Immunotherapeutics**](https://millionrounds.com/company/pionyr-immunotherapeutics) Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment. - $275M - [**Jupiter BioVentures**](https://millionrounds.com/company/jupiter-bioventures) Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects. United States $70M - [*M* **Mitokinin**](https://millionrounds.com/company/mitokinin) Mitokinin is operates in the healthcare industry focusing on biotechnology business. United States $5.0M - [**AmbAgon Therapeutics**](https://millionrounds.com/company/ambagon-therapeutics) Ambagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, partic United States $5.0M - [*AT* **Avexegen Therapeutics**](https://millionrounds.com/company/avexegen-therapeutics) Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders. - $2.9M - [**Tangible Science**](https://millionrounds.com/company/tangible-science) Tangible Science is a specialty contact lens care company based in Redwood City, California. United States $1.4M ### Series C and later 6 startups · $681M raised - [**Circle Pharma**](https://millionrounds.com/company/circle-pharma) Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides. United States $187M - [**Glycomine**](https://millionrounds.com/company/glycomine) Glycomine is an early-stage biotech working on replacement therapies for rare diseases. United States $160M - [*ST* **SiteOne Therapeutics**](https://millionrounds.com/company/siteone-therapeutics) United States $119M - [**Effector Therapeutics**](https://millionrounds.com/company/effector-therapeutics) Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics. United States $99M - [**Vivace Therapeutics**](https://millionrounds.com/company/vivace-therapeutics) Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. United States $75M - [**Symic Bio**](https://millionrounds.com/company/symic-bio) Symic Bio is a biopharmaceutical company based in San Francisco, California, founded in 2012. United States $41M ### Pre-seed and seed 5 startups · $67M raised - [**Cloverleaf Bio**](https://millionrounds.com/company/cloverleaf-bio) Cloverleaf Bio is a biotechnology company based in New Haven, Connecticut, founded in 2023. United States $33M - [**Enodia Therapeutics**](https://millionrounds.com/company/enodia-therapeutics) Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases. France $24M - [**TippingPoint Biosciences**](https://millionrounds.com/company/tippingpoint-biosciences) TippingPoint Biosciences is a biotechnology company based in San Francisco, California, dedicated to developing innovative therapi United States $4.5M - [**Deck Bio**](https://millionrounds.com/company/deck-bio) Deck Bio develops multi-target T cell engager immunotherapies for solid tumors. United States $3.1M - [*BB* **Beech Biotech**](https://millionrounds.com/company/beech-biotech) Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues. Switzerland $2.4M ### Series A 3 startups · $122M raised - [*PT* **Progentos Therapeutics**](https://millionrounds.com/company/progentos-therapeutics) Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms. United States $65M - [**March Biosciences**](https://millionrounds.com/company/march-biosciences) March Biosciences is a clinical-stage cell therapy company based in Houston, Texas. United States $29M - [*CT* **Comet Therapeutics**](https://millionrounds.com/company/comet-therapeutics) Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders. United States $29M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Mission BioCapital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Mission BioCapital** 26 co-investors](https://millionrounds.com/portfolio-maps/mission-biocapital-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like Mission BioCapital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)